Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000473850 | SCV000554284 | benign | Cowden syndrome | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001533820 | SCV001750687 | benign | not provided | 2020-09-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451149 | SCV002614583 | likely benign | Inborn genetic diseases | 2022-02-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003316577 | SCV004016569 | benign | Cowden syndrome 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001533820 | SCV004149438 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | PIK3CA: BP4, BP7, BS1 |
Breakthrough Genomics, |
RCV001533820 | SCV005302472 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001796063 | SCV002034312 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001533820 | SCV002036374 | likely benign | not provided | no assertion criteria provided | clinical testing |